TROG Cancer Research
Members Login   CQMS Login

- Submission process

Four types of New Proposals are accepted by TROG:

  • Category A: An investigator-initiated new proposal which can be submitted by a full TROG member. These proposals are to be submitted in response to the annual call for new proposals. 
  • Category B: An existing trial or new trial concept submitted by a full TROG member on behalf of a recognised Collaborative Trials Group and where TROG acts in the role of the ANZ sponsor. The trial is carried out under the joint auspices of TROG and the group concerned. 
    These proposals may be submitted to TROG at any time thought out the year.
  • Category C: An existing trial or new trial concept submitted by a full TROG member on behalf of a recognised Collaborative Trials Group and where TROG does not act in the role of the ANZ sponsor. TROG endorses the trial and promotes it through our media channels. 
    These proposals may be submitted to TROG at any time thought out the year.
  • Category D:  An investigator-initiated project or registry that involves data capture, data mining or secondary analysis.
    These proposals may be submitted to TROG at any time thought out the year. Depending on the complexity of the project, the proposal may require presentation at the ASM prior to being accepted for development.

To submit a new proposal for consideration, please complete and forward the TROG New Proposal Form to

For detailed information on the progression of trials through TROGs trial timeline please refer to the Policy statements page of the TROG Policy Statement TPS E3 Guidelines.

2017 Call for NEW PROPOSALS - CLOSED for Catergory A

New Proposal Timelines;

- Opening date: 02 August 2017
- Closing date: 15 September 2017
- TROG Scientific Committee (TSC) review: October 2017
- Proponent notification: October 2017
- EoI questionnaires circulated to TROG sites: December 2017
- Results of EoIs to Proponent: January 2017
- Presentation of proposal at the 2018 Annual Scientific Meeting19-22 March 2017 (Hobart, TAS)
- Notification of outcome: March 2018

Our values are collaboration, quality and care.

Latest News

  • 16 May 2018

    the inaugural trog trek has raised more than $10,000 for trog's cancer clinical trials. the group of volunteers took on a five-day 50 kilometre trek in the spectacular bay of fires region in north east tasmania in march. each of the team members either held fundraising events or...

  • 16 May 2018

    p style="font-variant-ligatures: normal;font-variant-caps: normal;orphans: 2; text-align:start;widows: 2;-webkit-text-stroke-width: 0px;text-decoration-style: initial; text-decoration-color: initial;word-spacing:0px">span style="font-size:11.0pt; font-family:">trog board presid...

  • 16 May 2018

    more than 270 people attended the trog 2018 annual scientific meeting (asm) in hobart, tasmania from 19-22 march. the asm was the 30th for trog and attendees included oncologists, radiation therapists, physicists, study coordinators and data managers. delegates heard from a host of...

  • 27 Feb 2018

    trog stalwart professor bryan burmeister is retiring from his position at princess alexandra hospital (pah) in brisbane. the highly respected radiation oncologist has worked in various positions with queensland health for 29 years. he has been at pah for the past 16 years. profe...

  • 06 Feb 2018

    with every millimetre counting in radiation therapy treatment, a new world first study developed in australia could eventually benefit cancer patients across the world. a new trog study called 'liver ablative radiotherapy with kim' or td 17.03 lark has received $583,000 from the ca...

  • 06 Feb 2018

    a new study investigating the use of cutting-edge stereotactic ablative _ radiotherapy (sabr) to treat patients with inoperable kidney cancer has been received $589,000 in funding from cancer australia. trog researcher, a/prof shankar siva, from the university of melbourne and the ...

  • 22 Jan 2018

    figure>img alt="file 20180117 53310 9zjg6j.jpg?ixlib=rb 1.1" src="" /> figcaption>a liquid biopsy is far less invasive than a standard biopsy, where a...

  • 01 Dec 2017

    fabulous food was the highlight of the recent trog trek fundraising dinner, with apprentice chefs from the kurri kurri tafe cooking up a feast of culinary delights. the students put all their learnings to the test to come up with a spectacular three course gourmet meal. the even...

  • 01 Dec 2017

    a new international trial, which will examine whether the addition of a new type of targeted radiation treatment is more effective for patients with advanced lung, breast or prostate cancer, is now up and running in australia. trog cancer research will lead the trial in australia c...

  • 20 Nov 2017

    trog cancer research is pleased to announce the appointment of john cleary to its board. ceo joan torony said that john was a perfect fit for trog’s board as he has more than 20 years’ experience at a senior management and executive level in both the not-for-profit and for-profit indu...

  • 20 Nov 2017

    more than 65 people showed their support for cancer research by attending a high tea fundraising event hosted by trog cancer research. the event was held in newcastle, where the trog cancer research has its headquarters. on top of a delicious high tea, guests also took part in a silen...

  • 14 Nov 2017

    westmead hospital is now home to a world-first prostate cancer trial, using revolutionary technology to dramatically slash treatment times.  trog's spark trial is underway in several nsw hospitals. it uses an australian-developed technology called kilovoltage intrafraction monitori...

  • 17 Jul 2017

    p style="text-align: center;">_ src="/sitefiles/trogcomau/julie_with_mask.jpg" style="height: 338px; width: 600px;" /> trog cancer research is excited to announce julie mccrossin, well-known and respected broadcaster, journalist and former tv host, as its new ambassador. julie has ...

  • 17 Jul 2017

    alex carmichael has always been a busy man. during his career he was an executive working for many major australian companies. he's also served as a director of public companies and on the board of many government organisations. he's always been interested in building a better society...

  • 04 Jul 2017

    margaret and narelle first met when they were in year four at primary school. the pair have stayed friends since this time and now they are embarking on a trip of a life-time - trekking the wilds of tasmania, raising vital funds for cancer research. margaret and narelle have decide...

  • 16 Jun 2017

    patients with advanced skin cancer can now be spared from having to undergo chemotherapy, with results from a new australian study showing that surgery combined with radiotherapy is a more effective treatment. professor sandro porceddu who headed the trog cancer research ‘post’ tri...

  • 30 May 2017

    in a brain cancer breakthrough, an international clinical trial , has found that adding temozolomide chemotherapy during short-course radiation therapy, followed by monthly maintenance doses of temozolomide, significantly improved survival of elderly patients with glioblastoma (gbm), ...

  • 30 May 2017

    in a world-first breakthrough for early stage low-grade lymphoma, set to change the management of the disease worldwide, an international clinical trial has found that patients live longer when immuno-chemotherapy is combined with radiotherapy. the results of the international phas...